Goodfellow Clinics

SGLT2 inhibitors and how we use them

02.24.2021 - By Goodfellow UnitPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this podcast, Dr Rick Cutfield discusses the management of type two diabetes mellitus following the introduction of new funded medication in NZ.

He covers the importance of lifestyle, medication, and support at every step, and also the pharmacological management including the new stepwise approach to management.

Indications and precautions of the new classes of subsidised medications: Sodium glucose co-transporter 2 (SGLT-2) inhibitors, and briefly Glucagon like peptide-1 receptor (GLP-1) agonists are also covered.

More episodes from Goodfellow Clinics